Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)

S. Siena; G. Demetri; R. Doebele; Y. Chae; P. Conkling; I. Garrido-Laguna; P. Garrido; C. Rolfo; D. Sigal; S. Eng; B. Simmons; C. Ye; F. Ciardiello

doi:10.1093/annonc/mdz154.023

Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)

S. Siena, G. Demetri, R. Doebele, Y. Chae, P. Conkling, I. Garrido-Laguna, P. Garrido, C. Rolfo, D. Sigal, S. Eng, B. Simmons, C. Ye, F. Ciardiello

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Original language	English (US)
Pages (from-to)	iv134
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz154.023
State	Published - Jul 1 2019

ASJC Scopus subject areas

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdz154.023

Cite this

Siena, S., Demetri, G., Doebele, R., Chae, Y., Conkling, P., Garrido-Laguna, I., Garrido, P., Rolfo, C., Sigal, D., Eng, S., Simmons, B., Ye, C., & Ciardiello, F. (2019). Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001). Annals of oncology : official journal of the European Society for Medical Oncology, 30, iv134. https://doi.org/10.1093/annonc/mdz154.023

@article{7c37077eafaa4ee686e231f28d0b0a00,

title = "Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)",

author = "S. Siena and G. Demetri and R. Doebele and Y. Chae and P. Conkling and I. Garrido-Laguna and P. Garrido and C. Rolfo and D. Sigal and S. Eng and B. Simmons and C. Ye and F. Ciardiello",

year = "2019",

month = jul,

day = "1",

doi = "10.1093/annonc/mdz154.023",

language = "English (US)",

volume = "30",

pages = "iv134",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Siena, S, Demetri, G, Doebele, R, Chae, Y, Conkling, P, Garrido-Laguna, I, Garrido, P, Rolfo, C, Sigal, D, Eng, S, Simmons, B, Ye, C & Ciardiello, F 2019, 'Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, pp. iv134. https://doi.org/10.1093/annonc/mdz154.023

Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001). / Siena, S.; Demetri, G.; Doebele, R. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, 01.07.2019, p. iv134.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Entrectinib in NTRK-fusion positive gastrointestinal cancers

T2 - integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)

AU - Siena, S.

AU - Demetri, G.

AU - Doebele, R.

AU - Chae, Y.

AU - Conkling, P.

AU - Garrido-Laguna, I.

AU - Garrido, P.

AU - Rolfo, C.

AU - Sigal, D.

AU - Eng, S.

AU - Simmons, B.

AU - Ye, C.

AU - Ciardiello, F.

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85079401562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079401562&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz154.023

DO - 10.1093/annonc/mdz154.023

M3 - Article

C2 - 32085042

SN - 0923-7534

VL - 30

SP - iv134

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Siena S, Demetri G, Doebele R, Chae Y, Conkling P, Garrido-Laguna I et al. Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001). Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Jul 1;30:iv134. doi: 10.1093/annonc/mdz154.023

Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this